Feferman Tali, Im Sin-Hyeog, Fuchs Sara, Souroujon Miriam C
Department of Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel.
J Neuroimmunol. 2003 Jul;140(1-2):153-8. doi: 10.1016/s0165-5728(03)00209-1.
The acetylcholine receptor (AChR) is the major autoantigen in the antibody-mediated disease myasthenia gravis (MG) and its animal model experimental autoimmune myasthenia gravis (EAMG). This study demonstrates that rats immunized with a recombinant fragment corresponding to the normally exposed extracellular region of the rat AChR alpha-subunit first develop antibodies to the injected extracellular portion only, but later develop antibodies to intracellular cytoplasmic epitopes of AChR. The presence of autoantibodies to intracellular epitopes seems to be correlated with development of clinical signs of disease. We propose that a similar process of epitope spreading may take place in the natural course of myasthenia.
乙酰胆碱受体(AChR)是抗体介导疾病重症肌无力(MG)及其动物模型实验性自身免疫性重症肌无力(EAMG)中的主要自身抗原。本研究表明,用对应于大鼠AChRα亚基正常暴露的细胞外区域的重组片段免疫的大鼠,最初仅产生针对注射的细胞外部分的抗体,但随后产生针对AChR细胞内细胞质表位的抗体。针对细胞内表位的自身抗体的存在似乎与疾病临床症状的发展相关。我们提出,在重症肌无力的自然病程中可能发生类似的表位扩展过程。